Cargando…

Boric Acid Exhibits Anticancer Properties in Human Endometrial Cancer Ishikawa Cells

Objective This study aims to explore the potential anti-cancer properties of boric acid (BA) in human endometrial cancer Ishikawa cells by assessing its influence on cell viability, apoptosis, oxidative stress, and inflammatory responses. Methods The impact of BA at concentrations ranging from 2.5 t...

Descripción completa

Detalles Bibliográficos
Autores principales: Çakır Gündoğdu, Ayşe, Arı, Neziha Senem, Höbel, Asiye, Şenol, Gülnihal, Eldiven, Ömer, Kar, Fatih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531031/
https://www.ncbi.nlm.nih.gov/pubmed/37772231
http://dx.doi.org/10.7759/cureus.44277
_version_ 1785111625420767232
author Çakır Gündoğdu, Ayşe
Arı, Neziha Senem
Höbel, Asiye
Şenol, Gülnihal
Eldiven, Ömer
Kar, Fatih
author_facet Çakır Gündoğdu, Ayşe
Arı, Neziha Senem
Höbel, Asiye
Şenol, Gülnihal
Eldiven, Ömer
Kar, Fatih
author_sort Çakır Gündoğdu, Ayşe
collection PubMed
description Objective This study aims to explore the potential anti-cancer properties of boric acid (BA) in human endometrial cancer Ishikawa cells by assessing its influence on cell viability, apoptosis, oxidative stress, and inflammatory responses. Methods The impact of BA at concentrations ranging from 2.5 to 100 mM on cell viability was assessed in Ishikawa cells and normal fibroblast L929 cells (used as the control) through the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Spectrophotometric measurements were performed to determine the total oxidant status (TOS) and total antioxidant status (TAS) in BA-treated cells, and the oxidative stress index (OSI) was calculated. The enzyme-linked immunosorbent assay (ELISA) was used to measure the levels of cytochrome c and caspase 3, both of which are constituents of the extrinsic apoptotic pathway. Furthermore, changes in the concentrations of pro-inflammatory cytokines tumor necrosis factor-alpha (TNF-α) and interleukin-1beta (IL-1β) in the cells were analyzed using ELISA and immunofluorescence staining. Results The exposure of Ishikawa cells to BA for 24 hours led to a dose-dependent decline in cell viability, with an IC(50) value of 40 mM. BA dose-dependently increased cytochrome c and caspase 3 levels in cancer cells. In Ishikawa cells, BA treatment led to a significant elevation in OSI. Moreover, the concentrations of TNF-α and IL-1β exhibited a dose-dependent decrease in BA-treated cells. On the other hand, in L929 cells, BA decreased OSI in a dose-dependent manner but did not change TNF-α and IL-1β levels. Concentrations up to 80 mM had no effect on cell viability and apoptosis, but BA at 80 mM concentration decreased viability and increased cytochrome c and caspase 3 levels in L929 cells. Conclusion BA inhibited cell viability, triggered apoptosis, induced oxidative stress, and suppressed inflammatory responses in endometrial cancer cells. Notably, at its IC(50) concentration, BA had no cytotoxic effect on normal fibroblasts. Given its favorable properties, BA may provide a valuable therapeutic option to impede the development and progression of endometrial cancer.
format Online
Article
Text
id pubmed-10531031
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-105310312023-09-28 Boric Acid Exhibits Anticancer Properties in Human Endometrial Cancer Ishikawa Cells Çakır Gündoğdu, Ayşe Arı, Neziha Senem Höbel, Asiye Şenol, Gülnihal Eldiven, Ömer Kar, Fatih Cureus Oncology Objective This study aims to explore the potential anti-cancer properties of boric acid (BA) in human endometrial cancer Ishikawa cells by assessing its influence on cell viability, apoptosis, oxidative stress, and inflammatory responses. Methods The impact of BA at concentrations ranging from 2.5 to 100 mM on cell viability was assessed in Ishikawa cells and normal fibroblast L929 cells (used as the control) through the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Spectrophotometric measurements were performed to determine the total oxidant status (TOS) and total antioxidant status (TAS) in BA-treated cells, and the oxidative stress index (OSI) was calculated. The enzyme-linked immunosorbent assay (ELISA) was used to measure the levels of cytochrome c and caspase 3, both of which are constituents of the extrinsic apoptotic pathway. Furthermore, changes in the concentrations of pro-inflammatory cytokines tumor necrosis factor-alpha (TNF-α) and interleukin-1beta (IL-1β) in the cells were analyzed using ELISA and immunofluorescence staining. Results The exposure of Ishikawa cells to BA for 24 hours led to a dose-dependent decline in cell viability, with an IC(50) value of 40 mM. BA dose-dependently increased cytochrome c and caspase 3 levels in cancer cells. In Ishikawa cells, BA treatment led to a significant elevation in OSI. Moreover, the concentrations of TNF-α and IL-1β exhibited a dose-dependent decrease in BA-treated cells. On the other hand, in L929 cells, BA decreased OSI in a dose-dependent manner but did not change TNF-α and IL-1β levels. Concentrations up to 80 mM had no effect on cell viability and apoptosis, but BA at 80 mM concentration decreased viability and increased cytochrome c and caspase 3 levels in L929 cells. Conclusion BA inhibited cell viability, triggered apoptosis, induced oxidative stress, and suppressed inflammatory responses in endometrial cancer cells. Notably, at its IC(50) concentration, BA had no cytotoxic effect on normal fibroblasts. Given its favorable properties, BA may provide a valuable therapeutic option to impede the development and progression of endometrial cancer. Cureus 2023-08-28 /pmc/articles/PMC10531031/ /pubmed/37772231 http://dx.doi.org/10.7759/cureus.44277 Text en Copyright © 2023, Çakır Gündoğdu et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Oncology
Çakır Gündoğdu, Ayşe
Arı, Neziha Senem
Höbel, Asiye
Şenol, Gülnihal
Eldiven, Ömer
Kar, Fatih
Boric Acid Exhibits Anticancer Properties in Human Endometrial Cancer Ishikawa Cells
title Boric Acid Exhibits Anticancer Properties in Human Endometrial Cancer Ishikawa Cells
title_full Boric Acid Exhibits Anticancer Properties in Human Endometrial Cancer Ishikawa Cells
title_fullStr Boric Acid Exhibits Anticancer Properties in Human Endometrial Cancer Ishikawa Cells
title_full_unstemmed Boric Acid Exhibits Anticancer Properties in Human Endometrial Cancer Ishikawa Cells
title_short Boric Acid Exhibits Anticancer Properties in Human Endometrial Cancer Ishikawa Cells
title_sort boric acid exhibits anticancer properties in human endometrial cancer ishikawa cells
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531031/
https://www.ncbi.nlm.nih.gov/pubmed/37772231
http://dx.doi.org/10.7759/cureus.44277
work_keys_str_mv AT cakırgundogduayse boricacidexhibitsanticancerpropertiesinhumanendometrialcancerishikawacells
AT arınezihasenem boricacidexhibitsanticancerpropertiesinhumanendometrialcancerishikawacells
AT hobelasiye boricacidexhibitsanticancerpropertiesinhumanendometrialcancerishikawacells
AT senolgulnihal boricacidexhibitsanticancerpropertiesinhumanendometrialcancerishikawacells
AT eldivenomer boricacidexhibitsanticancerpropertiesinhumanendometrialcancerishikawacells
AT karfatih boricacidexhibitsanticancerpropertiesinhumanendometrialcancerishikawacells